The Role of IL28B Genotype Testing in the Era of Direct Acting Antiviral Agents

le Osinusi, Anu, Naggie, Susanna
Foilsithe 2012

Rapid Development of Advanced Liver Fibrosis after Acquisition of Hepatitis C Infection during Primary HIV Infection

le Osinusi, Anu, Kleiner, David, Wood, Brad, Polis, Michael, Masur, Henry, Kottilil, Shyam
Foilsithe 2009

Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin

le Meissner, Eric G., Nelson, Amy, Marti, Miriam, Masur, Henry, Osinusi, Anu, Kottilil, Shyam
Foilsithe in Open Forum Infect Dis (2014)

Utility of Hepatitis C Viral Load Monitoring on Direct-Acting Antiviral Therapy

le Sidharthan, Sreetha, Kohli, Anita, Sims, Zayani, Nelson, Amy, Osinusi, Anu, Masur, Henry, Kottilil, Shyam
Foilsithe in Clin Infect Dis (2015)

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

le Osinusi, Anu, Chary, Aarthi, Winters, Mark A., Naggie, Susanna, Masur, Henry, Polis, Michael A., Kottilil, Shyam, Holodniy, Mark
Foilsithe 2012

Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects

le Humeniuk, Rita, Mathias, Anita, Cao, Huyen, Osinusi, Anu, Shen, Gong, Chng, Estelle, Ling, John, Vu, Amanda, German, Polina
Foilsithe in Clin Transl Sci (2020)

Inteleukin-23 Promotes Interferon-α Responsiveness in Hepatitis C Virus/HIV-Coinfected Patients

le Odigie, Madeline, Osinusi, Anu, Barrett, Lisa, Townsend, Kerry, Wang, Honghui, Suffredini, Anthony F., Masur, Henry, Polis, Michael A., Kottilil, Shyam
Foilsithe 2014

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

le Tang, Lydia Shuk Yee, Masur, Jack, Sims, Zayani, Nelson, Amy, Osinusi, Anu, Kohli, Anita, Kattakuzhy, Sarah, Polis, Michael, Kottilil, Shyam
Foilsithe in World J Hepatol (2016)

Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineage

le Hostager, Reilly, Ragonnet-Cronin, Manon, Murrell, Ben, Hedskog, Charlotte, Osinusi, Anu, Susser, Simone, Sarrazin, Christoph, Svarovskaia, Evguenia, Wertheim, Joel O
Foilsithe in Virus Evol (2019)

Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration

le Townsend, Kerry, Meissner, Eric G., Sidharthan, Sreetha, Sampson, Maureen, Remaley, Alan T., Tang, Lydia, Kohli, Anita, Osinusi, Anu, Masur, Henry, Kottilil, Shyam
Foilsithe in AIDS Res Hum Retroviruses (2016)

476. Gilead Sciences’ Commitment to the COVID-19 Pandemic

le Lee, EunYoung, Osinusi, Anu, Chokkalingam, Anand, Brainard, Diana M, Tran, Tram, Dau, Lauren, Ferrinho, Diogo, Wang, ChenYu, Juneja, Kavita
Foilsithe in Open Forum Infect Dis (2020)

ITPA Gene Polymorphisms Significantly Affect Hemoglobin Decline and Treatment Outcomes in Patients Coinfected With HIV and HCV

le Osinusi, Anu, Naggie, Susanna, Poonia, Seerat, Trippler, Martin, Hu, Zonghui, Funk, Emily, Schlaak, Joerg, Fishbein, Dawn, Masur, Henry, Polis, Michael, Kottilil, Shyam
Foilsithe 2012

Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus

le Shrivastava, Shikha, Bhatta, Manasa, Ward, Haley, Romani, Sara, Lee, Rebecca, Rosenthal, Elana, Osinusi, Anu, Kohli, Anita, Masur, Henry, Kottilil, Shyam, Wilson, Eleanor
Foilsithe in Hepatol Commun (2018)

Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients

le Kushner, Lauren E., Wendelboe, Aaron M., Lazzeroni, Laura C., Chary, Aarthi, Winters, Mark A., Osinusi, Anu, Kottilil, Shyam, Polis, Michael A., Holodniy, Mark
Foilsithe 2013

Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes

le Chaturvedi, Nimisha, Svarovskaia, Evguenia S, Mo, Hongmei, Osinusi, Anu O, Brainard, Diana M, Subramanian, G Mani, McHutchison, John G, Zeuzem, Stefan, Fellay, Jacques
Foilsithe in eLife (2019)

HIV/Hepatitis C Virus–Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders Do

le Osinusi, Anu, Rasimas, Joseph J., Bishop, Rachel, Proschan, Michael, McLaughlin, Mary, Murphy, Alison, Cortez, Karoll J., Polis, Michael A., Masur, Henry, Rosenstein, Donald, Kottilil, Shyam
Foilsithe 2010

Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin

le Petersen, Tess, Lee, Yu-Jin, Osinusi, Anu, Amorosa, Valerianna K., Wang, Crystal, Kang, Minhee, Matining, Roy, Zhang, Xiao, Dou, Diana, Umbleja, Triin, Kottilil, Shyam, Peters, Marion G.
Foilsithe in AIDS Res Hum Retroviruses (2016)

Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations

le Naggie, Susanna, Clement, Meredith, Lusk, Sam, Osinusi, Anu, Himmel, Tiffany, Lucas, Joseph E., Thompson, Will J., Dubois, Laura, Moseley, M. Arthur, Clark, Paul J., Kottilil, Shyam, Patel, Keyur
Foilsithe in Proteomics Clin Appl (2018)

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor

le Humeniuk, Rita, Mathias, Anita, Kirby, Brian J., Lutz, Justin D., Cao, Huyen, Osinusi, Anu, Babusis, Darius, Porter, Danielle, Wei, Xuelian, Ling, John, Reddy, Y. Sunila, German, Polina
Foilsithe in Clin Pharmacokinet (2021)

Serum and cellular ribavirin pharmacokinetic and concentration–effect analysis in HCV patients receiving sofosbuvir plus ribavirin

le Rower, Joseph E., Meissner, Eric G., Jimmerson, Leah C., Osinusi, Anu, Sims, Zayani, Petersen, Tess, Bushman, Lane R., Wolfe, Pamela, McHutchison, John G., Kottilil, Shyamasundaran, Kiser, Jennifer J.
Foilsithe in J Antimicrob Chemother (2015)